【 Quick News 】 Academician Wang Xiangdong visits Jili Biology for guidance

Recently, Academician Wang Xiangdong, a member of the European Academy of Humanities and Natural Sciences, a distinguished professor at Fudan University, the chief respiratory scientist at Zhongshan Hospital affiliated with Fudan University, the director of the Shanghai Institute of Clinical Bioinformatics, the director of the Shanghai Artificial Intelligence Technology Engineering Center for Cardiopulmonary Diseases, the director of the Fudan University Clinical Bioinformatics Center, and the deputy director of the Shanghai Institute of Respiratory Diseases, visited Amount Biotechnology for guidance. The company's chairman, Zhong Yangyang, and technical director, Luo Min, accompanied the visit and exchanged views on the scientific research and application of our company's biological preparation and analysis technology.

Academician Wang Xiangdong, as an authoritative expert in clinical translational medicine and clinical bioinformatics, has profound academic achievements and has made outstanding contributions to the development of biomedical science. The visit of Academician Wang not only brought us a feast of ideas, but also provided new inspiration and motivation for the future development of Amount Biology with his forward-looking vision and profound industry insights. We also look forward to transforming cutting-edge scientific research achievements into practical production capacity and contributing our strength to the progress of the industry.

Professor Wang Xiangdong holds a medical doctorate and is a member of the European Academy of Sciences. Currently a distinguished professor at Fudan University, Chief Scientist of Zhongshan Hospital, Discipline Leader of Clinical Medical Research Institute, Director of Shanghai Institute of Clinical Bioinformatics, Director of Shanghai Cardiovascular Disease Artificial Intelligence Technology Engineering Center, Director of Fudan University Clinical Bioinformatics Center, and Deputy Director of Shanghai Institute of Respiratory Disease. He is the Chief Scientist of the National Precision Medicine Major Project, the Key Project Leader of the National Natural Science Foundation, the Chairman of the Genetic Testing Technology Branch of the China Medical Biotechnology Association, the Vice Chairman and General Secretary of the Clinical Precision Medicine Professional Committee of the Chinese Medical Association, the Vice President and Council Member of the World Chinese Medical Association, the Vice Chairman of the World Chinese Oncology Association, and an Advisor to the Chinese Medical Association.